As Pres. Trump and Commerce Sec. Lutnick are overhauling the pharmaceutical industry, their children are positioning themselves to benefit from those shifts. W/ @jdawsey1
(Free link)
wsj.com/health/pharma/…
(Free link)
wsj.com/health/pharma/…
Donald Trump is on the board of a company, BlinkRx, that helps drugmakers do the DTC sales that Trump is pushing.
And BlinkRx + 1789 Capital are planning a CEO summit to convene drug company leaders plus admin officials including the CMS director Ox and head of the FDA
And BlinkRx + 1789 Capital are planning a CEO summit to convene drug company leaders plus admin officials including the CMS director Ox and head of the FDA
As Lutnick has pushed tariffs to onshore drug companies, the firm his children run took a stake in a SPAC that is looking to merge with companies that bring drug companies to the US.
It was a biggest SPAC offering of 2025 (at $500M).
It was a biggest SPAC offering of 2025 (at $500M).
• • •
Missing some Tweet in this thread? You can try to
force a refresh
